These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8593524)

  • 21. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management.
    Li S; He Z; Luo Y; Ji Y; Luo G; Fang Q; Gao Y
    BMC Pregnancy Childbirth; 2020 Sep; 20(1):539. PubMed ID: 32938441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-U and haemolytic disease of the fetus and newborn.
    Smith G; Knott P; Rissik J; de la Fuente J; Win N
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1318-21. PubMed ID: 9883926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-anti-D antibodies in red-cell alloimmunization.
    Lobo GA; Nardozza LM; Camano L
    Int J Gynaecol Obstet; 2006 Aug; 94(2):139-40. PubMed ID: 16828096
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of maternal anti-D concentrations during pregnancy.
    Filbey D; Berseus O; Sandström B; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody.
    Phung TV; Houfflin-Debarge V; Ramdane N; Ghesquière L; Delsalle A; Coulon C; Subtil D; Vaast P; Garabedian C
    Transfusion; 2018 May; 58(5):1199-1205. PubMed ID: 29512164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation.
    Oud JA; Evers D; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; Albersen A; van der Bom JG; Zwaginga JJ
    Br J Haematol; 2021 Nov; 195(4):604-611. PubMed ID: 34346067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell antibodies detected in antenatal tests on rhesus positive women in South and Mid Wales, 1948-1978.
    Hardy J; Napier JA
    Br J Obstet Gynaecol; 1981 Feb; 88(2):91-100. PubMed ID: 6779854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
    Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of prenatal patients using a combined antibody titre for Rh and non-Rh antibodies.
    Farrell M; Clarke G; Barr G; Hannon J
    Transfus Med; 2020 Jun; 30(3):210-214. PubMed ID: 31957093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells.
    Voak D; Williams MA
    Br J Haematol; 1971 Jan; 20(1):9-23. PubMed ID: 5099693
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythroblastosis fetalis produced by anti-k.
    Bowman JM; Harman FA; Manning CR; Pollock JM
    Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alloimmunization against platelets, granulocytes and erythrocytes in multi-transfused patients in Iranian population.
    Younesi MR; Louni Aligoudarzi S; Bigdeli R; Lashgari M; Mazaheri H; Asgary V
    Transfus Apher Sci; 2016 Oct; 55(2):205-211. PubMed ID: 27318433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemolytic disease of the newborn caused by anti-c, anti-E and anti-Fya antibodies: report of five cases.
    Babinszki A; Berkowitz RL
    Prenat Diagn; 1999 Jun; 19(6):533-6. PubMed ID: 10416968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.